Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
UTI Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesEQ - SUN PHARMACEUTICALS INDUSTRIES9.4231661016105.3990
Domestic EquitiesEQ - CIPLA LTD.5.684040000063.5760
Domestic EquitiesEQ - AJANTA PHARMA LTD.5.375424267360.1247
Domestic EquitiesEQ - LUPIN LTD.4.574127000051.1623
Domestic EquitiesEQ - DR REDDYS LABORATORIES LTD.4.055736000045.3636
Domestic EquitiesEQ - PROCTOR & GAMBLE HEALTH LTD3.98887003944.6148
Domestic EquitiesEQ - FORTIS HEALTHCARE LTD.3.789446500042.3848
Domestic EquitiesEQ - GLENMARK PHARMACEUTICALS LTD.3.784122000042.3258
Domestic EquitiesEQ - APOLLO HOSPITALS ENTERPRISE LT3.60605300040.3330
Domestic EquitiesEQ - ALKEM LABORATORIES LTD3.41397200038.1852
Domestic EquitiesEQ - GLAND PHARMA LTD.3.334619929737.2984
Domestic EquitiesEQ - ERIS LIFESCIENCES LTD2.883517915832.2520
Domestic EquitiesEQ- JUPITER LIFE LINE HOSPITALS LTD2.862022697232.0121
Domestic EquitiesEQ - CAPLIN POINT LABORATORIES LTD2.814415000031.4790
Domestic EquitiesEQ - DIVIS LABORATORIES LTD.2.74095000030.6575
Domestic EquitiesEQ - COHANCE LIFESCIENCES LIMITED2.488831612427.8379
Domestic EquitiesEQ - MAX HEALTHCARE INSTITUTE LTD2.476824000027.7032
Domestic EquitiesEQ - AUROBINDO PHARMA LTD.2.297525000025.6975
Domestic EquitiesEQ - KRISHNA INSTITUTE OF MEDI SCIE2.285535313225.5632
Domestic EquitiesEQ - IPCA LABORATORIES LTD.1.945115715621.7567
Domestic EquitiesEQ - METROPOLIS HEALTHCARE LTD1.90359728521.2908
Domestic EquitiesEQ- GLOBAL HEALTH LTD.1.817614796620.3305
Domestic EquitiesEQ - PFIZER LIMITED1.73853771419.4453
Domestic EquitiesEQ - SAI LIFE SCIENCES LTD1.693122962318.9370
Domestic EquitiesEQ - ASTER DM HEALTHCARE LTD1.639030500018.3320
Domestic EquitiesEQ - ANTHEM BIOSCIENCES LTD1.539721052217.2218
Domestic EquitiesEQ - WINDLAS BIOTEC LTD1.432716050716.0250
Domestic EquitiesEQ - SEQUENT SCIENTIFIC LTD1.319187114514.7546
Domestic EquitiesEQ - BIOCON LTD.1.179737878813.1951
Domestic EquitiesEQ - MARKSANS PHARMA LTD.1.138175500012.7293
Domestic EquitiesEQ - ACUTAAS CHEMICALS LIMITED1.12168922412.5449
Domestic EquitiesEQ - SANOFI CONSUMER HEALTHCARE INDIA LTD1.11012394512.4164
Domestic EquitiesEQ - VIJAYA DIAGNOSTIC CENTRE LTD1.081212000012.0936
Domestic EquitiesEQ - RAINBOW CHILDRENS MEDICARE LTD1.05627865011.8140
Domestic EquitiesEQ - SYNGENE INTERNATIONAL LTD.1.007218000011.2662
Domestic EquitiesEQ - TORRENT PHARMACEUTICALS LTD.0.95483000010.6794
Domestic EquitiesEQ - EMCURE PHARMACEUTICALS LTD0.93437500010.4505
Domestic EquitiesEQ - ALEMBIC PHARMACEUTICALS0.916010935010.2455
Domestic EquitiesEQ - JUBILANT PHARMOVA LIMITED0.8203896759.1746
Domestic EquitiesEQ - ORCHID PHARMA LTD.0.65631000007.3405
Domestic EquitiesEQ - LAXMI DENTAL LIMITED0.46561526215.2082
Total 99.3482 1111.2219
Cash & Cash Equivalents and Net AssetsNET CURRENT ASSETS0.6428 7.1900
Total 0.6428 7.1900
Deposits (Placed as Margin)CLEARING CORPORATION OF INDIA LTD. STD - MARGIN0.008900.1000
Total 0.0089 0.1000
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.